Skyler Johnson, MD is currently a chief resident in Radiation Oncology at Yale, a Yale Health Sciences Research Fellow as part of the National Clinical Scholars Program (NCSP; formerly RWJ) and a member of the Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER). During medical school, he worked on prostate cancer clinical outcomes research with the Radiation Oncology Department at University of Michigan. His research interests include cancer clinical trials, clinical outcomes, comparative effectiveness, cancer survivorship, cost-effectiveness and decision analysis, and investigations of novel therapeutics with radiation.